{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:17:13Z","timestamp":1759331833511,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T00:00:00Z","timestamp":1691107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","award":["Grant number 15584"],"award-info":[{"award-number":["Grant number 15584"]}],"id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11033-023-08704-x","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T08:02:01Z","timestamp":1691136121000},"page":"8073-8079","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Quinolone resistance and biofilm formation capability of uropathogenic Escherichia coli isolates from an Iranian inpatients\u2019 population"],"prefix":"10.1007","volume":"50","author":[{"given":"Elham","family":"Rastegar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalda","family":"Malekzadegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2413-2078","authenticated-orcid":false,"given":"Reza","family":"Khashei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahal","family":"Hadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"issue":"5","key":"8704_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ (2015) Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol 13(5):269\u2013284","journal-title":"Nat Rev Microbiol"},{"key":"8704_CR2","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.3389\/fmicb.2017.01566","volume":"8","author":"ME Terlizzi","year":"2017","unstructured":"Terlizzi ME, Gribaudo G, Maffei ME (2017) Uropathogenic Escherichia coli (UPEC) infections: virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front Microbiol 8:1566","journal-title":"Front Microbiol"},{"issue":"7","key":"8704_CR3","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/cid\/ciw396","volume":"63","author":"E Walker","year":"2016","unstructured":"Walker E, Lyman A, Gupta K, Mahoney MV, Snyder GM, Hirsch EB (2016) Clinical management of an increasing threat: outpatient urinary tract infections due to multidrug-resistant uropathogens. Clin Infect Dis 63(7):960\u2013965","journal-title":"Clin Infect Dis"},{"issue":"1","key":"8704_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.yexmp.2008.03.007","volume":"85","author":"TJ Wiles","year":"2008","unstructured":"Wiles TJ, Kulesus RR, Mulvey MA (2008) Origins and virulence mechanisms of uropathogenic Escherichia coli. Exp Mol pathol 85(1):11\u201319","journal-title":"Exp Mol pathol"},{"issue":"6","key":"8704_CR5","first-page":"841","volume":"14","author":"AE Karshenas","year":"2022","unstructured":"Karshenas AE, Salehi TZ, Adabi M, Asghari B, Yahyaraeyat R (2022) Prevalence of main quinolones and carbapenems resistance genes in clinical and veterinary Escherichia coli strains. Iran J Microbiol 14(6):841\u2013849","journal-title":"Iran J Microbiol"},{"key":"8704_CR6","doi-asserted-by":"publisher","first-page":"681473","DOI":"10.1155\/2012\/681473","volume":"2012","author":"J Bien","year":"2012","unstructured":"Bien J, Sokolova O, Bozko P (2012) Role of uropathogenic Escherichia coli virulence factors in development of urinary tract infection and kidney damage. Int J Nephrol 2012:681473","journal-title":"Int J Nephrol"},{"issue":"10","key":"8704_CR7","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.3390\/ijms18102077","volume":"18","author":"AR Eberly","year":"2017","unstructured":"Eberly AR, Floyd KA, Beebout CJ, Colling SJ, Fitzgerald MJ, Stratton CW et al (2017) Biofilm formation by uropathogenic Escherichia coli is favored under oxygen conditions that mimic the bladder environment. Int J Mol Sci 18(10):2077","journal-title":"Int J Mol Sci"},{"issue":"1","key":"8704_CR8","first-page":"195","volume":"35","author":"A Pootong","year":"2018","unstructured":"Pootong A, Mungkornkeaw N, Norrapong B, Cowawintaweewat S (2018) Phylogenetic background, drug susceptibility and virulence factors of uropathogenic E. coli isolate in a tertiary university hospital in central Thailand. Trop Biomed 35(1):195\u2013204","journal-title":"Trop Biomed"},{"issue":"1","key":"8704_CR9","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.juro.2006.08.081","volume":"177","author":"S Soto","year":"2007","unstructured":"Soto S, Smithson A, Martinez J, Horcajada J, Mensa J, Vila J (2007) Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. J Urol 177(1):365\u2013368","journal-title":"J Urol"},{"issue":"5","key":"8704_CR10","doi-asserted-by":"publisher","first-page":"e0196260","DOI":"10.1371\/journal.pone.0196260","volume":"13","author":"A Pompilio","year":"2018","unstructured":"Pompilio A, Crocetta V, Savini V, Petrelli D, Di Nicola M, Bucco S et al (2018) Phylogenetic relationships, biofilm formation, motility, antibiotic resistance and extended virulence genotypes among Escherichia coli strains from women with community-onset primitive acute pyelonephritis. PLoS ONE 13(5):e0196260","journal-title":"PLoS ONE"},{"issue":"4","key":"8704_CR11","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.21608\/nrmj.2022.251024","volume":"6","author":"B Kumar Shrestha","year":"2022","unstructured":"Kumar Shrestha B, Tumbahangphe M, Shakya J, Chauhan S (2022) Uropathogenic Escherichia coli in urinary tract infections: a review on epidemiology, pathogenesis, clinical manifestation, diagnosis, treatments and prevention. Nov Res Microbiol J 6(4):1614\u20131634","journal-title":"Nov Res Microbiol J"},{"key":"8704_CR12","volume-title":"Nitrofurantoin","author":"FJ Squadrito","year":"2022","unstructured":"Squadrito FJ, del Portal D (2022) Nitrofurantoin. StatPearls Publishing, Florida"},{"issue":"9","key":"8704_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/tropicalmed7090235","volume":"7","author":"HE Dzib-Baak","year":"2022","unstructured":"Dzib-Baak HE, Uc-Cach\u00f3n AH, Dzul-Beh AdJ, Rosado-Manzano RF, Gracida-Osorno C, Molina-Salinas GM (2022) Efficacy of fosfomycin against planktonic and biofilm-associated MDR uropathogenic Escherichia coli clinical isolates. Trop Med Infect Dis 7(9):235","journal-title":"Trop Med Infect Dis"},{"key":"8704_CR14","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2147\/IJGM.S11767","volume":"4","author":"D Minardi","year":"2011","unstructured":"Minardi D, d\u2019Anzeo G, Cantoro D, Conti A, Muzzonigro G (2011) Urinary tract infections in women: etiology and treatment options. Int J Gen Med 4:333\u2013343","journal-title":"Int J Gen Med"},{"issue":"1","key":"8704_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3947\/ic.2018.50.1.67","volume":"50","author":"C-I Kang","year":"2018","unstructured":"Kang C-I, Kim J, Park DW, Kim B-N, Ha U-S, Lee S-J et al (2018) Clinical practice guidelines for the antibiotic treatment of community-acquired urinary tract infections. Infect Chem 50(1):67\u2013100","journal-title":"Infect Chem"},{"issue":"1","key":"8704_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-3467-0","volume":"18","author":"Y Malekzadegan","year":"2018","unstructured":"Malekzadegan Y, Khashei R, Sedigh Ebrahim-Saraie H, Jahanabadi Z (2018) Distribution of virulence genes and their association with antimicrobial resistance among uropathogenic Escherichia coli isolates from iranian patients. BMC Infect Dis 18(1):1\u20139","journal-title":"BMC Infect Dis"},{"issue":"1","key":"8704_CR17","doi-asserted-by":"publisher","first-page":"e0190729","DOI":"10.1371\/journal.pone.0190729","volume":"13","author":"LR Varughese","year":"2018","unstructured":"Varughese LR, Rajpoot M, Goyal S, Mehra R, Chhokar V, Beniwal V (2018) Analytical profiling of mutations in quinolone resistance determining region of gyrA gene among UPEC. PLoS ONE 13(1):e0190729","journal-title":"PLoS ONE"},{"issue":"2","key":"8704_CR18","first-page":"163","volume":"6","author":"D Hassan","year":"2022","unstructured":"Hassan D, El-Moaafy MA, Saleh HH, Abdelrahman AA, Abdallah SE (2022) Characterization of quinolone resistance genes in uropathogenic Escherichia coli isolates, in Egypt. Rec Pharm Biomed Sci 6(2):163\u2013172","journal-title":"Rec Pharm Biomed Sci"},{"issue":"1","key":"8704_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1139\/cjm-2018-0275","volume":"65","author":"NA Lerminiaux","year":"2019","unstructured":"Lerminiaux NA, Cameron AD (2019) Horizontal transfer of antibiotic resistance genes in clinical environments. Can J Microbiol 65(1):34\u201344","journal-title":"Can J Microbiol"},{"key":"8704_CR20","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/npjbiofilms.2016.22","volume":"2","author":"T Stalder","year":"2016","unstructured":"Stalder T, Top E (2016) Plasmid transfer in biofilms: a perspective on limitations and opportunities. NPJ Biofilms Microbiomes 2:16022","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"1","key":"8704_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/1758-2229.12019","volume":"5","author":"O Clermont","year":"2013","unstructured":"Clermont O, Christenson JK, Denamur E, Gordon DM (2013) The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo\u2010groups. Environ Microbiol Rep 5(1):58\u201365","journal-title":"Environ Microbiol Rep"},{"key":"8704_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1471-2180-10-161","volume":"10","author":"C Carlos","year":"2010","unstructured":"Carlos C, Pires MM, Stoppe NC, Hachich EM, Sato MI, Gomes TA et al (2010) Escherichia coli phylogenetic group determination and its application in the identification of the major animal source of fecal contamination. BMC Microbiol 10:161","journal-title":"BMC Microbiol"},{"key":"8704_CR23","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.micpath.2015.10.014","volume":"89","author":"DK Er","year":"2015","unstructured":"Er DK, Dundar D, Uzuner H, Osmani A (2015) Relationship between phylogenetic groups, antibiotic resistance and patient characteristics in terms of adhesin genes in cystitis and pyelonephritis isolates of Escherichia coli. Microb pathog 89:188\u2013194","journal-title":"Microb pathog"},{"key":"8704_CR24","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing. CLSI supplement M100. PCaLSI","author":"CLSI","year":"2020","unstructured":"CLSI (2020) Performance Standards for Antimicrobial Susceptibility Testing. CLSI supplement M100. PCaLSI, 30th edn. Clinical and Laboratory Standards Institute, Wayne","edition":"30"},{"key":"8704_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jgar.2019.07.029","volume":"20","author":"VR Gajamer","year":"2020","unstructured":"Gajamer VR, Bhattacharjee A, Paul D, Ingti B, Sarkar A, Kapil J et al (2020) High prevalence of carbapenemase, AmpC \u03b2-lactamase and aminoglycoside resistance genes in extended-spectrum \u03b2-lactamase-positive uropathogens from Northern India. J Glob Antimicrob Resist 20:197\u2013203","journal-title":"J Glob Antimicrob Resist"},{"issue":"2","key":"8704_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1093\/jac\/dkm204","volume":"60","author":"V Cattoir","year":"2007","unstructured":"Cattoir V, Poirel L, Rotimi V, Soussy C-J, Nordmann P (2007) Multiplex PCR for detection of plasmid-mediated quinolone resistance qnr genes in ESBL-producing enterobacterial isolates. J Antimicrob Chemothe 60(2):394\u2013397","journal-title":"J Antimicrob Chemothe"},{"key":"8704_CR27","first-page":"e2437","volume":"47","author":"GA O\u2019Toole","year":"2011","unstructured":"O\u2019Toole GA (2011) Microtiter dish biofilm formation assay. JoVE 47:e2437","journal-title":"JoVE"},{"key":"8704_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0924-8579(03)00238-3","volume":"22","author":"TM Hooton","year":"2003","unstructured":"Hooton TM (2003) Fluoroquinolones and resistance in the treatment of uncomplicated urinary tract infection. Int J Antimicrob Agents 22:65\u201372","journal-title":"Int J Antimicrob Agents"},{"key":"8704_CR29","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.2147\/IDR.S206966","volume":"12","author":"Y Malekzadegan","year":"2019","unstructured":"Malekzadegan Y, Rastegar E, Moradi M, Heidari H, Ebrahim-Saraie HS (2019) Prevalence of quinolone-resistant uropathogenic Escherichia coli in a tertiary care hospital in south Iran. Infect Drug Resist 12:1683\u20131689","journal-title":"Infect Drug Resist"},{"issue":"12","key":"8704_CR30","first-page":"1226","volume":"21","author":"M Shenagari","year":"2018","unstructured":"Shenagari M, Bakhtiari M, Mojtahedi A, Roushan ZA (2018) High frequency of mutations in gyrA gene associated with quinolones resistance in uropathogenic Escherichia coli isolates from the north of Iran. Iran J Basic Med Sci 21(12):1226\u20131231","journal-title":"Iran J Basic Med Sci"},{"issue":"2","key":"8704_CR31","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1590\/S1517-83822011000200008","volume":"42","author":"I Muhammad","year":"2011","unstructured":"Muhammad I, Uzma M, Yasmin B, Mehmood Q, Habib B (2011) Prevalence of antimicrobial resistance and integrons in Escherichia coli from Punjab, Pakistan. Braz J Microbiol 42(2):462\u2013466","journal-title":"Braz J Microbiol"},{"key":"8704_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.4103\/abr.abr_116_17","volume":"7","author":"F Poursina","year":"2018","unstructured":"Poursina F, Sepehrpour S, Mobasherizadeh S (2018) Biofilm formation in nonmultidrug-resistant Escherichia coli isolated from patients with urinary tract infection in Isfahan, Iran. Adv Biomed Res 7:40","journal-title":"Adv Biomed Res"},{"issue":"2","key":"8704_CR33","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1128\/AAC.01051-08","volume":"53","author":"HB Kim","year":"2009","unstructured":"Kim HB, Park CH, Kim CJ, Kim E-C, Jacoby GA, Hooper DC (2009) Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period. Antimicrob Agents Chemother 53(2):639\u2013645","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"8704_CR34","doi-asserted-by":"publisher","first-page":"e19184","DOI":"10.5812\/jjm.19184v2","volume":"8","author":"I Sedighi","year":"2015","unstructured":"Sedighi I, Arabestani MR, Rahimbakhsh A, Karimitabar Z, Alikhani MY (2015) Dissemination of extended-spectrum \u03b2-lactamases and quinolone resistance genes among clinical isolates of uropathogenic Escherichia coli in children. Jundishapur J Microbiol 8(7):e19184","journal-title":"Jundishapur J Microbiol"},{"issue":"5","key":"8704_CR35","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.phrp.2016.08.003","volume":"7","author":"M Rezazadeh","year":"2016","unstructured":"Rezazadeh M, Baghchesaraei H, Peymani A (2016) Plasmid-mediated quinolone-resistance (qnr) genes in clinical isolates of Escherichia coli collected from several hospitals of Qazvin and Zanjan provinces, Iran. Osong Public Health Res Perspect 7(5):307\u2013312","journal-title":"Osong Public Health Res Perspect"},{"issue":"9","key":"8704_CR36","doi-asserted-by":"publisher","first-page":"e67293","DOI":"10.5812\/jjm.67293","volume":"11","author":"S Yousefi","year":"2018","unstructured":"Yousefi S, Mojtahedi A, Shenagari M (2018) A Survey of gyrA target-site mutation and qnr genes among clinical isolates of Escherichia coli in the North of Iran. Jundishapur J Microbiol 11(9):e67293","journal-title":"Jundishapur J Microbiol"},{"issue":"66","key":"8704_CR37","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1128\/AEM.66.10.4555-4558.2000","volume":"10","author":"O Clermont","year":"2000","unstructured":"Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 10(66):4555\u20134558","journal-title":"Appl Environ Microbiol"},{"key":"8704_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5712371","author":"VC Cristea","year":"2019","unstructured":"Cristea VC, Gheorghe I, Czobor Barbu I, Popa LI, Ispas B, Grigore GA et al (2019) Snapshot of phylogenetic groups, virulence, and resistance markers in Escherichia coli uropathogenic strains isolated from outpatients with urinary tract infections in Bucharest,\u00a0Romania. BioMed Res Int. https:\/\/doi.org\/10.1155\/2019\/5712371","journal-title":"BioMed Res Int"},{"issue":"5","key":"8704_CR39","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jiph.2014.04.002","volume":"7","author":"A Harwalkar","year":"2014","unstructured":"Harwalkar A, Gupta S, Rao A, Srinivasa H (2014) Lower prevalence of hlyD, papC and cnf-1 genes in ciprofloxacin-resistant uropathogenic Escherichia coli than their susceptible counterparts isolated from southern India. J Infect Public Health 7(5):413\u2013419","journal-title":"J Infect Public Health"},{"issue":"1","key":"8704_CR40","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12866-020-01933-1","volume":"20","author":"Z Yazdanpour","year":"2020","unstructured":"Yazdanpour Z, Tadjrobehkar O, Shahkhah M (2020) Significant association between genes encoding virulence factors with antibiotic resistance and phylogenetic groups in community acquired uropathogenic Escherichia coli isolates. BMC Microbiol 20(1):241","journal-title":"BMC Microbiol"},{"key":"8704_CR41","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cimid.2019.05.003","volume":"65","author":"SK Shokouhi Mostafavi","year":"2019","unstructured":"Shokouhi Mostafavi SK, Najar-Peerayeh S, Mohabbati Mobarez A, Kardoust Parizi M (2019) Serogroup distribution, diversity of exotoxin gene profiles, and phylogenetic grouping of CTX-M-1- producing uropathogenic Escherichia coli. Comp Immunol Microbiol Infect Dis 65:148\u2013153","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"8704_CR42","doi-asserted-by":"publisher","first-page":"846219","DOI":"10.1155\/2015\/846219","volume":"2015","author":"D Iranpour","year":"2015","unstructured":"Iranpour D, Hassanpour M, Ansari H, Tajbakhsh S, Khamisipour G, Najafi A (2015) Phylogenetic groups of Escherichia coli strains from patients with urinary tract infection in Iran based on the new Clermont phylotyping method. Biomed Res Int 2015:846219","journal-title":"Biomed Res Int"},{"issue":"1","key":"8704_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12866-022-02506-0","volume":"22","author":"S Derakhshan","year":"2022","unstructured":"Derakhshan S, Ahmadi S, Ahmadi E, Nasseri S, Aghaei A (2022) Characterization of Escherichia coli isolated from urinary tract infection and association between virulence expression and antimicrobial susceptibility. BMC Microbiol 22(1):89","journal-title":"BMC Microbiol"},{"key":"8704_CR44","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.micpath.2017.07.046","volume":"110","author":"Z Hashemizadeh","year":"2017","unstructured":"Hashemizadeh Z, Kalantar-Neyestanaki D, Mansouri S (2017) Association between virulence profile, biofilm formation and phylogenetic groups of Escherichia coli causing urinary tract infection and the commensal gut microbiota: a comparative analysis. Microb Pathog 110:540\u2013545","journal-title":"Microb Pathog"},{"key":"8704_CR45","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.2147\/IDR.S199764","volume":"12","author":"A Farajzadah Sheikh","year":"2019","unstructured":"Farajzadah Sheikh A, Goodarzi H, Yadyad MJ, Aslani S, Amin M, Jomehzadeh N et al (2019) Virulence-associated genes and drug susceptibility patterns of uropathogenic Escherichia coli isolated from patients with urinary tract infection. Infect Drug Resist 12:2039\u20132047","journal-title":"Infect Drug Resist"},{"issue":"4","key":"8704_CR46","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/pathogens5040065","volume":"5","author":"C Delcaru","year":"2016","unstructured":"Delcaru C, Alexandru I, Podgoreanu P, Grosu M, Stavropoulos E, Chifiriuc MC et al (2016) Microbial biofilms in urinary tract infections and prostatitis: etiology, pathogenicity, and combating strategies. Pathogens 5(4):65","journal-title":"Pathogens"},{"key":"8704_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13756-016-0109-4","volume":"5","author":"E Tajbakhsh","year":"2016","unstructured":"Tajbakhsh E, Ahmadi P, Abedpour-Dehkordi E, Arbab-Soleimani N, Khamesipour F (2016) Biofilm formation, antimicrobial susceptibility, serogroups and virulence genes of uropathogenic E. coli isolated from clinical samples in Iran. Antimicrob Resist Infect control 5:11","journal-title":"Antimicrob Resist Infect control"},{"issue":"3","key":"8704_CR48","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/S1995-7645(12)60026-1","volume":"5","author":"P Ponnusamy","year":"2012","unstructured":"Ponnusamy P, Natarajan V, Sevanan M (2012) In vitro biofilm formation by uropathogenic Escherichia coli and their antimicrobial susceptibility pattern. Asian Pac J Trop Med 5(3):210\u2013213","journal-title":"Asian Pac J Trop Med"},{"issue":"2","key":"8704_CR49","doi-asserted-by":"publisher","first-page":"175","DOI":"10.4103\/bbrj.bbrj_270_21","volume":"6","author":"N Jomehzadeh","year":"2022","unstructured":"Jomehzadeh N, Ahmadi K, Nasiri Z (2022) Evaluation of biofilm formation and antibiotic resistance pattern in extended-spectrum \u03b2-lactamase-producing Escherichia coli strains. Biomed Biotechnol Res J (BBRJ) 6(2):175\u2013179","journal-title":"Biomed Biotechnol Res J (BBRJ)"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08704-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-08704-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08704-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T15:20:12Z","timestamp":1695655212000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-08704-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["8704"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-08704-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2023,8,4]]},"assertion":[{"value":"11 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}},{"value":"This study was in accordance with the declaration of 1964 Helsinki and approved by the institutional Ethics Committee of Shiraz University of Medical Sciences (Approval No. IR. SUMS. REC. 1397.688). However, because we only used leftovers from clinical specimens, the institutional ethics committee waived the need for informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}